Littleton, CO – According to filings with the U.S. Securities and Exchange Commission, Vivos Therapeutics is raising $18,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Kirk Huntsman played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Vivos Therapeutics

At Vivos, we strive to provide useful information to help you when discussing your health concerns with your doctor. Our goal is to strengthen your relationship with your healthcare team to ensure proper diagnosis and treatment. Our business is helping to address challenges throughout the world. We are helping to reduce the overall cost of healthcare by targeting a prevalent condition which contributes to many of the most expensive healthcare problems. At Vivos, we support healthcare professionals around the world who are focused on treating the root cause of sleep disordered breathing including mild-to-moderate obstructive sleep apnea resulting from craniofacial deficiencies.

To learn more about Vivos Therapeutics, visit http://www.vivoslife.com/

Contact:
Kirk Huntsman, Chief Executive Officer
720-239-7366
kirk@vivoslife.com
https://www.linkedin.com/in/kirkhuntsman/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved